Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 23, 2007
Grant Date -
Feb 10, 2005
app pub date -
Nov 25, 2003
filing date -
Mar 27, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A human nucleic acid, PD2, its encoded protein and antibodies immunologically specific thereto are disclosed herein. The expression of the disclosed PD2 gene plays a key role in the regulation of differentiation and in the maintenance of the neoplastic state. The PD2 gene and its encoded protein represent valuable therapeutic targets in the differential diagnosis and therapy of pancreatic adenocarcinomas.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully